SEC
SlamSEC
SearchBrowseEarnings

Monte Rosa Therapeutics, Inc.

Nasdaq:GLUE
Biological Products, (No Diagnostic Substances)·BOSTON, MA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(325 total)

TypeDateAccessionPeriodSize
4
Mar 5, 2026
0001193125-26-0942964
Mar 4, 2026
4.7 KB
4
Mar 4, 2026
0001193125-26-0917334
Mar 2, 2026
5.0 KB
144
Mar 4, 2026
0001193125-26-091704
—
6.3 KB
4
Mar 2, 2026
0001193125-26-0856774
Feb 27, 2026
12.9 KB
144
Mar 2, 2026
0001965301-26-000022
—
5.5 KB
144
Mar 2, 2026
0001950047-26-001966
—
6.1 KB
144
Feb 27, 2026
0001950047-26-001887
—
5.4 KB
4
Feb 24, 2026
0001193125-26-0669554
Feb 23, 2026
4.3 KB
144
Feb 23, 2026
0001950047-26-001676
—
7.1 KB
SCHEDULE 13G/A
Feb 17, 2026
0000921895-26-000461
—
23.2 KB
SCHEDULE 13G/A
Feb 17, 2026
0001104659-26-016412
—
14.7 KB
S-3ASR
Feb 11, 2026
0001193125-26-046690S-3ASR
—
1.2 MB
8-K
Feb 10, 2026
0001193125-26-0446168-K
Feb 9, 2026
164.2 KB
SCHEDULE 13G/A
Jan 21, 2026
0001012975-26-000062
—
15.7 KB
8-K
Jan 9, 2026
0001193125-26-0090058-K
Jan 8, 2026
661.2 KB
424B5
Jan 9, 2026
0001193125-26-009001424B5
—
640.1 KB
SCHEDULE 13D/A
Jan 9, 2026
0001193125-26-008951
—
18.1 KB
4
Jan 9, 2026
0001193125-26-0089024
Jan 7, 2026
8.7 KB
144/A
Jan 8, 2026
0001965301-26-000002
—
5.0 KB
144
Jan 7, 2026
0001965301-26-000001
—
4.4 KB
8-K
Jan 7, 2026
0001193125-26-0063418-K
Jan 7, 2026
165.1 KB
424B5
Jan 7, 2026
0001193125-26-006297424B5
—
641.9 KB
8-K
Jan 7, 2026
0001193125-26-0054208-K
Jan 7, 2026
13.4 MB
4
Jan 5, 2026
0001193125-26-0024064
Jan 2, 2026
9.2 KB
4
Jan 5, 2026
0001193125-26-0024014
Jan 2, 2026
9.2 KB
25 filings shown